Cargando…
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis
Glioblastoma (GBM) is the most common primary brain tumor with median survival of approximately one year. This dismal poor prognosis is due to resistance to currently available chemotherapeutics; therefore, new cytotoxic agents are urgently needed. In the present study, we reported the cytotoxicity...
Autores principales: | Cao, Liang, Qu, Dingding, Wang, Huan, Zhang, Sha, Jia, Chenming, Shi, Zixuan, Wang, Zongren, Zhang, Jian, Ma, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133924/ https://www.ncbi.nlm.nih.gov/pubmed/27869737 http://dx.doi.org/10.3390/ijms17111928 |
Ejemplares similares
-
Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling
por: Chen, Tian-xing, et al.
Publicado: (2018) -
Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells
por: Zhang, Chaochao, et al.
Publicado: (2021) -
Toosendanin induces the apoptosis of human Ewing's sarcoma cells via the mitochondrial apoptotic pathway
por: Gao, Tian, et al.
Publicado: (2019) -
Natural product-derived icaritin exerts anti-glioblastoma effects by positively modulating estrogen receptor β
por: Li, Xiaowen, et al.
Publicado: (2020) -
Toosendanin Suppresses Glioma Progression Property and Induces Apoptosis by Regulating miR-608/Notch Axis
por: Wang, Qiong, et al.
Publicado: (2020)